Table 2 Results of the multivariate subdistribution hazard models for care level change and the competing event mortality, stratified by care level at admission

Female

1.03

0.97–1.10

0.76

0.69–0.82

< 0.001

1.04

0.96–1.13

0.85

0.80–0.90

< 0.001

Age (per 10-y increase)

1.02

0.98–1.07

1.41

1.31–1.52

< 0.001

0.85

0.80–0.90

< 0.001

1.26

1.20–1.32

< 0.001

Hospitalization stay (60 days before)

0.84

0.79–0.88

< 0.001

1.48

1.36–1.61

< 0.001

0.77

0.71–0.83

< 0.001

1.43

1.35–1.52

< 0.001

Myocardial infarction

0.81

0.70–0.92

< 0.01

1.33

1.14–1.55

< 0.001

0.79

0.65–0.96

< 0.02

1.29

1.15–1.44

< 0.001

Congestive heart failure

0.93

0.87–0.98

< 0.01

1.22

1.12–1.33

< 0.001

0.83

0.77–0.90

< 0.001

1.17

1.11–1.25

< 0.001

Peripheral vascular disorder

0.97

0.90–1.05

1.08

0.98–1.19

1.01

0.91–1.12

1.04

0.97–1.11

Cardiac arrhythmias

0.97

0.91–1.03

1.13

1.04–1.23

< 0.01

0.90

0.82–0.98

< 0.02

1.14

1.08–1.21

< 0.001

Valvular disease

0.95

0.87–1.04

1.11

1.00–1.25

0.94

0.83–1.07

1.05

0.97–1.14

Coagulopathy

0.86

0.74–0.99

< 0.04

1.12

0.95–1.33

0.87

0.70–1.09

1.07

0.94–1.22

Chronic pulmonary disease

0.95

0.89–1.02

1.14

1.04–1.25

< 0.01

0.93

0.84–1.02

1.11

1.04–1.18

< 0.01

Pulmonary circulation disorders

0.90

0.78–1.05

1.17

0.98–1.40

0.85

0.68–1.07

1.15

1.01–1.31

< 0.05

Rheumatoid arthritis/collagen vascular d.

0.95

0.85–1.05

0.99

0.85–1.15

0.91

0.79–1.06

1.06

0.96–1.18

Ulcer disease

0.83

0.71–0.98

< 0.03

1.24

1.01–1.53

< 0.05

0.91

0.72–1.13

1.04

0.91–1.19

Any tumor

0.91

0.83–0.99

< 0.04

1.44

1.30–1.60

< 0.001

0.72

0.63–0.82

< 0.001

1.50

1.39–1.62

< 0.001

Metastatic cancer

0.67

0.54–0.83

< 0.001

2.45

2.06–2.92

< 0.001

0.44

0.32–0.59

< 0.001

2.27

1.99–2.58

< 0.001

Cerebrovascular disease

1.06

1.00–1.12

0.94

0.86–1.03

0.98

0.91–1.06

1.01

0.95–1.07

Dementia

1.43

1.36–1.51

< 0.001

0.73

0.67–0.80

< 0.001

1.74

1.60–1.89

< 0.001

0.73

0.69–0.78

< 0.001

Neurodegenerative disorders

1.10

1.02–1.18

< 0.02

0.92

0.82–1.04

0.17

1.03

0.94–1.13

0.48

0.99

0.93–1.06

0.80

Paralysis

1.04

0.92–1.17

1.01

0.84–1.22

1.00

0.89–1.13

0.88

0.80–0.96

< 0.01

Complicated diabetes

1.05

0.96–1.15

0.95

0.83–1.08

0.90

0.79–1.02

1.10

1.00–1.20

< 0.05

Uncomplicated diabetes

1.04

0.97–1.11

1.04

0.94–1.14

1.00

0.91–1.09

1.00

0.93–1.06

Renal failure

0.97

0.90–1.05

1.19

1.08–1.31

< 0.001

0.88

0.79–0.97

< 0.02

1.16

1.08–1.24

< 0.001

Liver disease

1.06

0.96–1.17

0.99

0.86–1.14

0.90

0.77–1.05

1.05

0.94–1.16

Obesity

1.00

0.92–1.09

0.95

0.83–1.09

1.02

0.90–1.16

0.87

0.80–0.96

< 0.01

Depression

0.96

0.91–1.02

0.95

0.87–1.04

0.98

0.90–1.06

0.94

0.89–1.00

Hypertension

0.98

0.91–1.04

0.96

0.87–1.06

1.06

0.97–1.16

0.93

0.87–0.99

< 0.04

Hypothyroidism

0.96

0.87–1.06

0.98

0.84–1.13

1.07

0.94–1.23

0.91

0.82–1.01

Fluid and electrolyte disorders

1.08

1.00–1.17

< 0.04

1.03

0.93–1.15

1.00

0.91–1.10

1.04

0.97–1.11

Blood loss anemia

1.01

0.74–1.39

0.95

0.65–1.39

0.85

0.58–1.23

1.20

0.96–1.50

Deficiency anemias

0.93

0.83–1.03

1.09

0.95–1.25

0.92

0.79–1.07

1.08

0.97–1.19

Weight loss

0.87

0.76–1.01

1.51

1.27–1.78

< 0.001

0.85

0.70–1.04

1.38

1.23–1.55

< 0.001

Alcohol abuse

0.82

0.69–0.98

< 0.03

1.28

0.99–1.65

0.78

0.58–1.03

1.07

0.88–1.30

Drug abuse

0.98

0.75–1.29

0.65

0.39–1.08

1.06

0.71–1.58

1.01

0.76–1.35

Psychosis

0.93

0.84–1.05

1.00

0.83–1.21

0.95

0.81–1.11

0.88

0.78–1.00